NOVAVAX INC — Director's Dealing 2021

May 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-05-19

Reporting Person: King Rachel K. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-19	Common Stock	P	700	$139.64	Acquired	2800	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1100	Indirect
Common Stock	1100	Indirect

Footnotes

F1: Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.

F2: Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.